• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙日光性角化病的生活质量、行为及态度:PIQA研究

Quality of Life, Behaviour and Attitudes towards Actinic Keratosis in Spain: The PIQA Study.

作者信息

Longo I, Serra-Guillén C

机构信息

Hospital Central de la Defensa Gómez Ulla, Madrid, España.

Instituto Valenciano de Oncología, Valencia, España.

出版信息

Actas Dermosifiliogr (Engl Ed). 2018 May;109(4):331-339. doi: 10.1016/j.ad.2018.01.004. Epub 2018 Feb 22.

DOI:10.1016/j.ad.2018.01.004
PMID:29477269
Abstract

OBJECTIVE

This study was aimed to examine patients' knowledge, behaviours and attitudes regarding actinic keratosis (AK) lesions and the impact of the disease on patients' quality of life (QoL).

METHODS

Observational study of patients with AK lesions in Spain. QoL was evaluated with the validated version of Spanish AKQoL questionnaire. Skin self-examination, sun-exposure, habits and attitudes towards AK's treatment were recorded using different questionnaires. The adherence was assessed by means of the Morisky-Green test. Among other variables, QoL and adherence to treatment were compared by using Pearson's χ test and one-way ANOVA tests. Inferential analysis regarding such factors and length of treatment were also performed.

RESULTS

A total of 1240 patients (73.6 [10.5] years old) were recruited. Overall, patients that showed higher levels of concern were also showed a higher impairment on QoL. AK had greater effects on women's QoL and those who performed skin self-examination, think that AK is a disease and/or believe that moisturizers can prevent skin aging (P<.05). Adherence and length of treatment were strongly related, since patients with treatments intended for <1week were more likely to show good adherence and complete remission of AK (Odds Ratio [95%CI]: 6.25 [4.55-8.33] and 2.63 [1.96-3.45]), respectively).

CONCLUSIONS

Concerns due to AK are mainly related to sex and to the consideration of AK as a disease. More concerned patients tend to have lower QoL and good adherence to treatment. Short length of treatment was associated with better adherence and complete remission of AK lesions.

摘要

目的

本研究旨在调查患者对光化性角化病(AK)皮损的认知、行为和态度,以及该疾病对患者生活质量(QoL)的影响。

方法

对西班牙患有AK皮损的患者进行观察性研究。使用经过验证的西班牙版AKQoL问卷评估生活质量。通过不同问卷记录皮肤自我检查、日晒情况、习惯以及对AK治疗的态度。采用Morisky-Green测试评估依从性。在其他变量中,使用Pearson卡方检验和单向方差分析测试比较生活质量和治疗依从性。还对这些因素与治疗时长进行了推断性分析。

结果

共招募了1240名患者(年龄73.6 [10.5]岁)。总体而言,关注度较高的患者在生活质量方面的受损程度也较高。AK对女性的生活质量影响更大,以及那些进行皮肤自我检查、认为AK是一种疾病和/或相信保湿剂可预防皮肤老化的患者(P<0.05)。依从性与治疗时长密切相关,因为治疗时长小于1周的患者更有可能表现出良好的依从性且AK完全缓解(优势比[95%置信区间]:分别为6.25 [4.55 - 8.33]和2.63 [1.96 - 3.45])。

结论

对AK的担忧主要与性别以及将AK视为一种疾病有关。担忧程度较高的患者往往生活质量较低,但治疗依从性良好。治疗时长较短与AK皮损的更好依从性和完全缓解相关。

相似文献

1
Quality of Life, Behaviour and Attitudes towards Actinic Keratosis in Spain: The PIQA Study.西班牙日光性角化病的生活质量、行为及态度:PIQA研究
Actas Dermosifiliogr (Engl Ed). 2018 May;109(4):331-339. doi: 10.1016/j.ad.2018.01.004. Epub 2018 Feb 22.
2
Influence of demographic and clinical characteristics of actinic keratosis patients on illness perceptions and readiness to increase sun protection behaviours: an exploratory study.光化性角化病患者的人口统计学和临床特征对疾病认知及增加防晒行为意愿的影响:一项探索性研究
Photodermatol Photoimmunol Photomed. 2017 May;33(3):143-155. doi: 10.1111/phpp.12295. Epub 2017 Feb 22.
3
Swiss (German) Version of the Actinic Keratosis Quality of Life questionnaire.《光化性角化病生活质量问卷》瑞士(德语)版。
Dermatology. 2018;234(1-2):51-59. doi: 10.1159/000488053. Epub 2018 Apr 18.
4
Health related quality of life in patients with actinic keratosis--an observational study of patients treated in dermatology specialist care in Denmark.光化性角化病患者的健康相关生活质量——丹麦皮肤科专科护理中接受治疗患者的一项观察性研究
Health Qual Life Outcomes. 2015 Jul 29;13:111. doi: 10.1186/s12955-015-0295-4.
5
Patients' perspectives on actinic keratosis.患者对光化性角化病的看法。
Curr Probl Dermatol. 2015;46:8-13. doi: 10.1159/000366530. Epub 2014 Dec 18.
6
Quality of life and side effects in patients with actinic keratosis treated with ingenol mebutate: a pilot study.外用鬼臼毒素治疗光化性角化病患者的生活质量和副作用:一项试点研究。
Actas Dermosifiliogr. 2015 Oct;106(8):644-50. doi: 10.1016/j.ad.2015.04.014. Epub 2015 Jun 27.
7
Spanish version of the Actinic Keratosis Quality of Life questionnaire.《光化性角化病生活质量问卷》西班牙语版本。
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):986-991. doi: 10.1111/jdv.14127. Epub 2017 Feb 27.
8
Adaptation and validation of the Spanish version of the Actinic Keratosis Quality of Life questionnaire.《光化性角化病生活质量问卷》西班牙语版本的改编与验证
Actas Dermosifiliogr. 2016 Jul-Aug;107(6):474-81. doi: 10.1016/j.ad.2016.03.003. Epub 2016 Apr 12.
9
Differences in Disease-specific Quality of Life in Patients with Actinic Keratosis in Australia and Denmark.澳大利亚和丹麦光化性角化病患者特定疾病生活质量的差异。
Acta Dermatovenerol Croat. 2016 Apr;24(1):25-8.
10
Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.信息框架对患者治疗光化性角化病决策的影响。
JAMA Dermatol. 2017 May 1;153(5):421-426. doi: 10.1001/jamadermatol.2016.5245.

引用本文的文献

1
Epidemiology and Risk Factors of Actinic Keratosis. What is New for The Management for Sun-Damaged Skin.光化性角化病的流行病学与危险因素。日光损伤皮肤管理的新进展。
Dermatol Pract Concept. 2024 Sep 1;14(3 S1):e2024146S. doi: 10.5826/dpc.1403S1a146S.
2
International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.国际皮肤病学结局测量指标(IDEOM):2020 年年会报告。
Dermatology. 2022;238(3):430-437. doi: 10.1159/000518966. Epub 2021 Sep 17.
3
Guidelines of care for the management of actinic keratosis.光化性角化病治疗管理指南。
J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.
4
Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review.光化性角化病局部治疗的患者报告结局:系统评价。
Dermatol Ther. 2021 Mar;34(2):e14833. doi: 10.1111/dth.14833. Epub 2021 Feb 21.
5
Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization.光化性角化病与场癌化治疗的管理要点
Dermatol Ther (Heidelb). 2020 Oct;10(5):903-915. doi: 10.1007/s13555-020-00425-4. Epub 2020 Jul 17.